Science Explorer Interactive view Map
Company · Marlborough · United States

Phio Pharmaceuticals (United States)

phiopharma.comROR OpenAlex
Research works
58
▲ 73% vs 2013–17
Citations
439
7.5 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
52%
world 28%

Not ranked overall: Phio Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 6.87× its world share, 9 worksBiochemistry, Geneti…Immunology and Microbiology: 13.00× its world share, 3 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 4.93× its world share, 0 worksPharmacology, Toxico…Engineering: 0.23× its world share, 1 worksEngineeringMedicine: 2.33× its world share, 11 worksMedicinePsychology: 0.11× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 13.0×. Every wedge is a field page.

Who are the top researchers at Phio Pharmaceuticals (United States)?

Ranked on the composite score, James Cardia lead among researchers whose main affiliation is Phio Pharmaceuticals (United States).

  1. 1 James Cardia United States · #1,314,468 worldwide 27 citations · 16 works
All ranked researchers at Phio Pharmaceuticals (United States)

Which keywords describe research at Phio Pharmaceuticals (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer Immunotherapy, Immunotherapy, Tumor Regression, CAR T Cells, Chimeric Antigen Receptor, Gene Therapy, Innate Immunity and Dendritic Cells.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 25 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 25 words, with their numbers
  1. Cancer Immunotherapy7▲ 193×2 topics
  2. Immunotherapy6▲ 37×4 topics
  3. Tumor Regression5▲ 186×2 topics
  4. CAR T Cells5▲ 258×1 topic
  5. Chimeric Antigen Receptor5▲ 258×1 topic
  6. Gene Therapy3▲ 62×2 topics
  7. Dendritic Cells3▲ 118×1 topic
  8. Immunity3▲ 26×1 topic
  9. Innate Immunity3▲ 34×2 topics
  10. RNA Interference2▲ 121×1 topic
  11. siRNA Delivery2▲ 173×1 topic
  12. Cancer Therapy2▲ 16×4 topics
  13. Photodynamic Therapy2▲ 41×2 topics
  14. Transcriptional Regulation2▲ 56×2 topics
  15. BET Bromodomains2▲ 294×1 topic
  16. PROTACs2▲ 294×1 topic
  17. Tumor Microenvironment2▲ 18×2 topics
  18. Immune Checkpoint Blockade2▲ 59×1 topic
  19. PD-1 and PD-L12▲ 59×1 topic
  20. Nanoparticles2▲ 5.0×2 topics
  21. Nonmelanoma Skin Cancer1▲ 222×1 topic
  22. Skin Cancers1▲ 222×1 topic
  23. Proteasome Inhibitors1▲ 69×2 topics
  24. Tumor Targeting1▲ 27×2 topics
  25. Melanoma1▲ 70×2 topics

Which research topics does Phio Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, Immunotherapy and Immune Responses, RNA Interference and Gene Delivery and Protein Degradation and Inhibitors.

CAR-T cell therapy resea…5CAR-T cell therapy research: 5 fractional worksImmunotherapy and Immune Responses: 3 fractional worksRNA Interference and Gene Delivery: 2 fractional worksProtein Degradation and Inhibitors: 2 fractional worksCancer Immunotherapy and Biomarkers: 2 fractional worksNonmelanoma Skin Cancer …1Nonmelanoma Skin Cancer Studies: 1 fractional worksUbiquitin and proteasome pathways: 1 fractional worksNanoplatforms for cancer theranostics: 1 fractional worksCutaneous Melanoma Detection and Management: 1 fractional worksAdvanced biosensing and bioanalysis techniques: 1 fractional works
OncologyImmunologyMolecular BiologyEpidemiology1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 5 works
  2. 2 Immunotherapy and Immune Responses Immunology 3 works
  3. 3 RNA Interference and Gene Delivery Molecular Biology 2 works
  4. 4 Protein Degradation and Inhibitors Molecular Biology 2 works
  5. 5 Cancer Immunotherapy and Biomarkers Oncology 2 works
  6. 6 Nonmelanoma Skin Cancer Studies Epidemiology 1 works
  7. 7 Ubiquitin and proteasome pathways Molecular Biology 1 works
  8. 8 Nanoplatforms for cancer theranostics Biomedical Engineering 1 works
  9. 9 Cutaneous Melanoma Detection and Management Oncology 1 works
  10. 10 Advanced biosensing and bioanalysis techniques Molecular Biology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available52.5%not open47.5%

World: 28% of research is openly available.

with international co-authors16.8%domestic only83.2%

World: 19% is written across borders.

How has Phio Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 73% higher than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Marlborough

All research institutions in Marlborough

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.